Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents for neurodegenerative disorders to the CNS: implications for treating neuroAIDS [presentation]
Presentation
Overview
occurs within event
National Institutes of Health HIV Preclinical/Clinical Conference on NeuroAIDS
Research
keywords
Blood
Brain
Drugs and Drug Therapy
HIV-AIDS
Intranasal Administration
